Hospitals are contending with shortages of the life-saving supplies after Hurricane Helene damaged operations at a key manufacturing plant in North Carolina, according to the American Hospital ...

Catalyst Solutions, a leader in innovative solutions to Health Plans, has announced today that Rob Renzi has joined the company as Chief Growth Officer. Renzi brings more than 35 years of leadership ...

Startups notched 110 deals in the third quarter, compared with 133 in the second quarter. But average deal size held steady, suggesting investors are making “fewer, more focused bets,” according to ...

Only 25% of Humana members will be in plans with four stars or above next year, down from 94% this year, the insurer disclosed Wednesday. The downgrade could wipe out Humana’s profits in 2026.

For any data-driven initiative, quality is crucial. In medical imaging, this means ensuring data is accurate, complete, and consistently labeled. Poor-quality imaging data can lead to inefficient ...

Jason Stenta, who has held roles at Optum and CVS Health, joins as the company considers selling its stake in VillageMD and contends with shareholder litigation.

The CMS fails to check hospitals’ pricing data for accuracy and completeness, raising questions about whether the data can be used as intended to help payers and patients shop for services, according ...

The litigation comes as pharmacy benefit managers Express Scripts, CVS Caremark and Optum Rx have faced growing criticism over their role in high drug costs — including a recent lawsuit from the ...

A handful of plans owned by the nation's largest MA payer are the latest to ask the court to help raise their valuable quality scores.

As we begin this year’s Breast Cancer Awareness Month, Volpara Health, a Lunit company and a global leader in software for the early detection of cancer, publicly reaffirms its support for the ...

Mission Hospital’s emergency department is at double capacity as supply shortages create processing delays, nurses told Healthcare Dive.

A bipartisan group of two dozen representatives pushed officials to preserve the pandemic-era prescribing changes for buprenorphine, arguing telehealth increases access and prevents overdoses.